Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis

By sjmartinez • November 11, 2023

Curtis JR, Strand V, Golombek SJ, Karpouzas GA, Zhang L, Wong A, Patel K, Dines J, Akmaev VR. Decision Impact Analysis to Measure the Influence of Molecular Signature Response Classifier Testing on Treatment Selection in Rheumatoid Arthritis. Rheumatol Ther. 2023 Nov 10. doi: 10.1007/s40744-023-00618-1. Epub ahead of print. PMID: 37948030.

Tags: Harbor UCLA, Molecular signature, Precision medicine, Publications, Response classifier, Rheumatoid arthritis, Rheumatology, Treatment selection

Reply to the letter-to-editor: “on the preserved muscle oxidative capacity in COPD patients with hypoxemia treated by long term O2 therapy”

Adami A, Paneroni M, Vitacca M, Casaburi R, Rossiter HB. Reply to the letter-to-editor: "on the preserved muscle oxidative capacity in COPD patients with hypoxemia[...]

The transcription factor Ahr1 governs the recruitment of neutrophils to the brain and clearance of Candida albicans during CNS infection

Wakade RS, Solis NV, Ristow LC, Wellington M, Filler SG, Krysan DJ. The transcription factor Ahr1 governs the recruitment of neutrophils to the brain and[...]

Limitations of Spirometry in Firefighter Hiring

DeCato TW, Yee N, Stringer WW. Limitations of Spirometry in Firefighter Hiring. Am J Respir Crit Care Med. 2026 Jul 20:aamag376. doi: 10.1093/ajrccm/aamag376. Epub ahead[...]